ID
11719
Beschrijving
The purpose of this study is to compare the safety of two different dose regimens of unfractionated heparin (UFH) during a percutaneous coronary intervention (PCI) procedure in patients with UA (unstable angina)/NSTEMI (non ST segment elevation myocardial infarction) who have been initially treated with fondaparinux. https://clinicaltrials.gov/ct2/show/NCT00790907
Link
https://clinicaltrials.gov/ct2/show/NCT00790907
Trefwoorden
Versies (1)
- 28-07-15 28-07-15 -
Geüploaded op
28 juli 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility FUTURA/OASIS 8 Acute Coronary Syndrome NCT00790907
Eligibility Criteria
- StudyEvent: ODM
Beschrijving
Exclusion Criteria
Beschrijving
Age < 21 years
Datatype
boolean
Alias
- UMLS CUI-1
- C0001779
Beschrijving
Any contraindication to UFH
Datatype
boolean
Alias
- UMLS CUI-1
- C2825026
- UMLS CUI-2
- C0522473
Beschrijving
Any contraindication to fondaparinux
Datatype
boolean
Alias
- UMLS CUI-1
- C1098510
- UMLS CUI-2
- C0522473
Beschrijving
Contraindication for angiography or PCI at baseline
Datatype
boolean
Alias
- UMLS CUI-1
- C1532338
- UMLS CUI-2
- C0522473
Beschrijving
Contraindication for angiography at baseline
Datatype
boolean
Alias
- UMLS CUI-1
- C0085532
- UMLS CUI-2
- C0522473
Beschrijving
refractory or recurrent angina associated with dynamic ST-deviation
Datatype
boolean
Alias
- UMLS CUI-1
- C0002962
Beschrijving
heart failure
Datatype
boolean
Alias
- UMLS CUI-1
- C0018801
Beschrijving
life-threatening arrhythmias
Datatype
boolean
Alias
- UMLS CUI-1
- C0085612
Beschrijving
hemodynamic instability
Datatype
boolean
Alias
- UMLS CUI-1
- C0948268
Beschrijving
Subjects already receiving treatment with enoxaparin for treatment of the qualifying events
Datatype
boolean
Alias
- UMLS CUI-1
- C0206460
Beschrijving
Subjects already receiving treatment with LMWH for treatment of the qualifying events
Datatype
boolean
Alias
- UMLS CUI-1
- C3536766
Beschrijving
Subjects already receiving treatment with bivalirudin for treatment of the qualifying events
Datatype
boolean
Alias
- UMLS CUI-1
- C0168273
Beschrijving
Subjects already receiving treatment with UFH for treatment of the qualifying events
Datatype
boolean
Alias
- UMLS CUI-1
- C2825026
Beschrijving
Hemorrhagic stroke within the last 12 months.
Datatype
boolean
Alias
- UMLS CUI-1
- C0559159
Beschrijving
Indication for anti-coagulation other than acute coronary syndrome (ACS) during the index hospitalization.
Datatype
boolean
Alias
- UMLS CUI-1
- C0003281
Beschrijving
Pregnancy or women of childbearing potential who are not using an effective method of contraception.
Datatype
boolean
Alias
- UMLS CUI-1
- C0549206
Beschrijving
Co-morbid condition with life expectancy less than 6 months.
Datatype
boolean
Alias
- UMLS CUI-1
- C0679247
Beschrijving
Currently receiving an experimental pharmacological agent.
Datatype
boolean
Alias
- UMLS CUI-1
- C0304229
Beschrijving
Revascularization procedure already performed for the qualifying event.
Datatype
boolean
Alias
- UMLS CUI-1
- C0027056
Beschrijving
Severe renal insufficiency (i.e., estimated creatinine clearance <20 ml/min)
Datatype
boolean
Alias
- UMLS CUI-1
- C1533077
Similar models
Eligibility Criteria
- StudyEvent: ODM
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)